This powerful steroid, inexpensive, has proven to be effective to treat patients with the most severely affected by the Covid-19.
It is at this point the only drug that appears to improve survival in patients with the Covid-19. The WHO has called this Monday to increase production of dexamethasone this powerful steroid that has proven to be effective to treat patients with the most severely affected by the Covid-19.
“The next challenge is to increase the production and to distribute quickly and fairly, and dexamethasone in the world, focusing on the places where it is needed the most,” said the director general of the world Organization of health, Tedros Adhanom Ghebreyesus, during a virtual press conference from the headquarters of the organization, in Geneva. “Fortunately, it is an inexpensive medicine, and there are many manufacturers of dexamethasone in the world, which, we believe, can accelerate the production”, he added.
SEE ALSO >> what is the dexamethasone, this drug shows promise against the Covid-19 ?
Your support is essential. Subscribe for $ 1 support Us
According to the early clinical trial results in the british Recovery published on June 16, dexamethasone reduces by one third the mortality in patients with the most severely affected by the Covid-19. This drug is the first to show improved survival in patients of the Covid-19, while there is no vaccine. It is already used in many indications for its anti-inflammatory effect and powerful
The british study also showed that mortality was reduced by one fifth in patients less severely ill, who administered oxygen through a face mask without intubation. In contrast, the treatment showed no benefit for patients who did not need any respiratory assistance.
“The request has already jumped”
The director-general of WHO has pointed out that “the dexamethasone should only be used for the sick of Covid-19 in serious condition or critical, under close clinical monitoring”. “There is no evidence that this drug works for patients with a benign condition or as a preventive measure, and it could cause damage,” insisted the top un official.
In the wake of the publication of the results of the trial, the british government had announced that this treatment would be immediately used to treat the patients concerned. “The demand has already jumped”, following the publication of the results of the trial, the united kingdom, has unveiled Tedros Adhanom Ghebreyesus.
READ ALSO >> Dexamethasone against the Covid-19 : “Attention to the runaway media, and politics”
The director general of the WHO has called on the international community to show “solidarity” and “transparency” to the country with the largest number of critically ill patients receive the stocks of dexamethasone priority. He also asked that the stocks are also still available for treating other diseases for which dexamethasone is usually used.
“It is also important to ensure that the suppliers can ensure the quality of the products, “because there is a high risk that products of inferior quality or adulterated enter in the market,” noted the boss, WHO.
Read our complete file
“Covid-19”, the new coronavirus
Covid-19 : Shakira, Coldplay, Bieber in concert to support the search for a vaccine to LIVE. Covid-19 : the WHO calls for increased global production of dexamethasone Covid-19 : these 5 figures that show that the epidemic “continues to accelerate” in the world
on Friday, the giant south african pharmacy Aspen Pharmacare said he was ready to “accelerate” its production of dexamethasone. “We are able to accelerate the production if the demand requires it”, had assured one of the leaders of the group which markets, Dr. Stavros Nicolaou. “We are still evaluating what might be the global demand” of this drug, he added, “it is clear that if she increased very strongly we would have difficulties” to the meet. Dexamethasone, which are already used on a large scale,” in France, is manufactured in the form of tablets in a factory of Aspen in Germany, and injections, produced in several countries via trade agreements.
